Bedaquiline, Delamanid, Linezolid and Clofazimine for Treatment of Pre-extensively Drug-Resistant Tuberculosis.

Chandrasekaran Padmapriyadarsini,Vikram Vohra,Anuj Bhatnagar,Rajesh Solanki,Rathinam Sridhar, Lalitkumar Anande, M Muthuvijaylakshmi, Miraa Bhatia,Bharathi Jeyadeepa, Gaurav Taneja,S Balaji, Prashant Shah,N Saravanan, Vijay Chauhan,Hemanth Kumar,Chinnayin Ponnuraja, Viktoriya Livchits, Monica Bahl,Umesh Alavadi, K S Sachdeva,Soumya Swaminathan

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America（2022）

引用 22|浏览6

暂无评分

摘要

After 24-36 weeks of treatment, this regimen resulted in a satisfactory favorable outcome in pulmonary MDR-TB patients with additional drug resistance. Cardiotoxicity was minimal, and myelosuppression, while common, was detected early and treated successfully.

查看译文

关键词

Delamanid,Drug-resistant Tuberculosis,Effectiveness,Linezolid,Short-course

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要